# A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

> **NCT02859948** · PHASE1 · UNKNOWN · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** SKLB1028

## Key facts

- **NCT ID:** NCT02859948
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2017-12
- **Final completion:** 2018-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2016-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02859948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02859948, "A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02859948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*